AU2013360692B2 - Pharmaceutical formulation comprising ciclesonide - Google Patents

Pharmaceutical formulation comprising ciclesonide Download PDF

Info

Publication number
AU2013360692B2
AU2013360692B2 AU2013360692A AU2013360692A AU2013360692B2 AU 2013360692 B2 AU2013360692 B2 AU 2013360692B2 AU 2013360692 A AU2013360692 A AU 2013360692A AU 2013360692 A AU2013360692 A AU 2013360692A AU 2013360692 B2 AU2013360692 B2 AU 2013360692B2
Authority
AU
Australia
Prior art keywords
ciclesonide
ethanol
pharmaceutical formulation
acid
inhaler
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2013360692A
Other languages
English (en)
Other versions
AU2013360692A1 (en
Inventor
Balazs Albrecht
Michael Aven
Benjamin FRANZMANN
Matthias Hausmann
Janine LAMAR
Ingo Lang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Vetmedica GmbH
Original Assignee
Boehringer Ingelheim Vetmedica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica GmbH filed Critical Boehringer Ingelheim Vetmedica GmbH
Publication of AU2013360692A1 publication Critical patent/AU2013360692A1/en
Application granted granted Critical
Publication of AU2013360692B2 publication Critical patent/AU2013360692B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AU2013360692A 2012-12-21 2013-12-18 Pharmaceutical formulation comprising ciclesonide Active AU2013360692B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP12199302 2012-12-21
EP12199302.6 2012-12-21
EP13190393 2013-10-25
EP13190393.2 2013-10-25
PCT/EP2013/077266 WO2014096116A1 (en) 2012-12-21 2013-12-18 Pharmaceutical formulation comprising ciclesonide

Publications (2)

Publication Number Publication Date
AU2013360692A1 AU2013360692A1 (en) 2015-04-23
AU2013360692B2 true AU2013360692B2 (en) 2018-08-09

Family

ID=49779929

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013360692A Active AU2013360692B2 (en) 2012-12-21 2013-12-18 Pharmaceutical formulation comprising ciclesonide

Country Status (10)

Country Link
US (3) US10925964B2 (OSRAM)
EP (2) EP2934544B1 (OSRAM)
AU (1) AU2013360692B2 (OSRAM)
CA (1) CA2888431C (OSRAM)
DK (2) DK3473255T3 (OSRAM)
ES (2) ES2706757T3 (OSRAM)
IN (1) IN2015DN02999A (OSRAM)
LT (2) LT2934544T (OSRAM)
MX (1) MX364652B (OSRAM)
WO (1) WO2014096116A1 (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3473255T3 (da) 2012-12-21 2022-04-04 Boehringer Ingelheim Vetmedica Gmbh Farmaceutisk formulering omfattende ciclesonid
NZ706573A (en) 2012-12-21 2019-11-29 Boehringer Ingelheim Vetmedica Gmbh Ciclesonide for the treatment of airway disease in horses
DK3157522T3 (da) * 2014-06-18 2019-12-09 Boehringer Ingelheim Vetmedica Gmbh Muskarin-antagonister og kombinationer deraf til behandlingen af luftvejssygdomme i heste
PE20190622A1 (es) 2016-06-02 2019-04-26 Abbvie Inc Agonista del receptor de glucocorticoides e inmunoconjugados del mismo
MA49796A (fr) 2017-12-01 2020-06-03 Abbvie Inc Agoniste du récepteur des glucocorticoïdes et immunoconjugués de celui-ci

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040266869A1 (en) * 2000-12-15 2004-12-30 Montague Christopher John Novel medicament compositions based on anticholinesterase drugs and on ciclesonides
US20060069073A1 (en) * 2004-06-29 2006-03-30 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising steroids and an anticholinergic
US20060293293A1 (en) * 2003-05-22 2006-12-28 Altana Pharma Ag Salmeterol and ciclesonide combination
US20120058980A1 (en) * 2006-08-18 2012-03-08 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta agonists

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5954049A (en) * 1991-10-15 1999-09-21 Trudell Medical Limited Equine mask with MDI adapter
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
US5823179A (en) 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
US6264923B1 (en) 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
DE10050994A1 (de) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
US6706726B2 (en) 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
US6904908B2 (en) 2002-05-21 2005-06-14 Trudell Medical International Visual indicator for an aerosol medication delivery apparatus and system
US7244742B2 (en) 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
DE10237739A1 (de) 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
WO2004023984A2 (en) 2002-09-13 2004-03-25 Smith C Steven Novel composition and method for treatment of upper respiratory conditions
US8371292B2 (en) * 2003-09-16 2013-02-12 Nycomed Gmbh Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
AU2005235384B2 (en) 2004-04-20 2010-09-09 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
DE102004056579A1 (de) 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid
UY30543A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
EP2445558B1 (en) 2009-06-25 2016-06-29 Boehringer Ingelheim Vetmedica GmbH Inhaler
EA201590019A1 (ru) 2012-07-05 2015-09-30 Арвен Айлак Санайи Ве Тиджарет А.С. Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы
US20150202297A1 (en) 2012-07-05 2015-07-23 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Dry powder inhalers comprising a carrier other than lactose and a ternary component
US9539408B2 (en) 2012-10-31 2017-01-10 Trudell Medical International Nebulizer apparatus
NZ706573A (en) 2012-12-21 2019-11-29 Boehringer Ingelheim Vetmedica Gmbh Ciclesonide for the treatment of airway disease in horses
DK3473255T3 (da) 2012-12-21 2022-04-04 Boehringer Ingelheim Vetmedica Gmbh Farmaceutisk formulering omfattende ciclesonid
PL3035886T3 (pl) 2013-08-20 2021-05-31 Boehringer Ingelheim Vetmedica Gmbh Inhalator
HUE064186T2 (hu) 2013-08-20 2024-03-28 Boehringer Ingelheim Vetmedica Gmbh Inhalátor
DK3157522T3 (da) 2014-06-18 2019-12-09 Boehringer Ingelheim Vetmedica Gmbh Muskarin-antagonister og kombinationer deraf til behandlingen af luftvejssygdomme i heste

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040266869A1 (en) * 2000-12-15 2004-12-30 Montague Christopher John Novel medicament compositions based on anticholinesterase drugs and on ciclesonides
US20060293293A1 (en) * 2003-05-22 2006-12-28 Altana Pharma Ag Salmeterol and ciclesonide combination
US20060069073A1 (en) * 2004-06-29 2006-03-30 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising steroids and an anticholinergic
US20120058980A1 (en) * 2006-08-18 2012-03-08 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta agonists

Also Published As

Publication number Publication date
DK3473255T3 (da) 2022-04-04
EP3473255B1 (en) 2022-01-12
LT2934544T (lt) 2019-02-25
MX2015007731A (es) 2015-09-07
MX364652B (es) 2019-05-03
DK2934544T3 (en) 2019-03-04
ES2909039T3 (es) 2022-05-05
ES2706757T3 (es) 2019-04-01
EP2934544A1 (en) 2015-10-28
EP3473255A1 (en) 2019-04-24
US20240024482A1 (en) 2024-01-25
US20140179650A1 (en) 2014-06-26
EP2934544B1 (en) 2018-11-07
US11819549B2 (en) 2023-11-21
CA2888431A1 (en) 2014-06-26
LT3473255T (lt) 2022-03-10
AU2013360692A1 (en) 2015-04-23
US10925964B2 (en) 2021-02-23
WO2014096116A1 (en) 2014-06-26
CA2888431C (en) 2021-10-19
US20210106685A1 (en) 2021-04-15
IN2015DN02999A (OSRAM) 2015-09-25

Similar Documents

Publication Publication Date Title
US11819549B2 (en) Pharmaceutical formulation comprising ciclesonide
US10682345B2 (en) Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses
US10441597B2 (en) Ciclesonide for the treatment of airway disease in horses
JP2018016658A (ja) 新規噴射剤含有チオトロピウム製剤
WO2021140113A1 (en) Ciclesonide for ameliorating quality of life (qol) in equines

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)